Treatment of hypertension reduces cognitive decline in older adults: a systematic review and meta-analysis.

BMJ Open
Aditi GuptaGary Gronseth

Abstract

To systematically analyse the effect of pharmacological treatment of hypertension (HTN) on cognitive decline in older adults. Randomised, placebo-controlled trials with a prespecified quantitative outcome of cognition and a pharmacological intervention for at least 12 months to treat HTN in older adults (>60 years). Our primary outcome was change in cognition with pharmacological treatment of HTN. Standardised mean difference (SMD) was used to analyse different outcomes reported in the selected studies. We searched PubMed CENTRAL and the Cochrane Library from inception to 6 July 2020. Two independent reviewers assessed trial quality and extracted data. Internal and external validity of the studies was assessed. Nine randomised controlled trials with 34 994 participants were included in the final analysis. The net SMD for change in cognition was -0.049 (CI: -0.078 to -0.019) indicating that treatment of HTN decreased cognitive decline. Heterogeneity was low with an I² of 6%. Current evidence does not indicate worsening of cognition with treatment of HTN. Treatment of HTN in older adults may reduce cognitive decline. These results have important implications in clinical management of patients at risk for dementia. CRD42020139750.

References

Jan 1, 1991·Cardiovascular Drugs and Therapy·S Strandgaard
Apr 20, 1987·The Medical Journal of Australia·G J Hankey, S S Gubbay
Jan 1, 1995·Psychological Bulletin·V Hasselblad, L V Hedges
Sep 15, 1993·American Journal of Epidemiology·M F EliasL R White
Feb 5, 2005·Stroke; a Journal of Cerebral Circulation·Leonardo PantoniDomenico Inzitari
Jul 22, 2005·Lancet Neurology·Chengxuan QiuLaura Fratiglioni
Apr 16, 2011·International Journal of Geriatric Psychiatry·Sally I SharpClive Ballard
Jul 22, 2011·Lancet Neurology·Deborah E Barnes, Kristine Yaffe
Nov 29, 2011·International Journal of Hypertension·Michiya IgaseTetsuro Miki
Sep 6, 2012·JAMA : the Journal of the American Medical Association·Bernhard M KaessGary F Mitchell
Jan 12, 2013·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Martin PrinceCleusa P Ferri
Feb 5, 2014·JAMA Internal Medicine·Jeff D WilliamsonUNKNOWN Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Investigators
Jun 9, 2016·JAMA Neurology·Saloua AkoudadMeike W Vernooij
Apr 18, 2018·Journal of General Internal Medicine·Lifeng LinYong Chen
Sep 5, 2018·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Elżbieta KuźmaDavid J Llewellyn
Jan 29, 2019·JAMA : the Journal of the American Medical Association·UNKNOWN SPRINT MIND Investigators for the SPRINT Research GroupClinton B Wright
Jul 18, 2019·The New England Journal of Medicine·Alexander C FlintDeepak L Bhatt
May 20, 2020·JAMA : the Journal of the American Medical Association·Diarmaid HughesMichelle Canavan

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Software Mentioned

Comprehensive Meta - Analysis
Excel

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.